| Title | Author(s) | Year | View Count |  | Genetic and pharmacological inhibition of PDK1 in cancer cells: Characterization of a selective allosteric kinase inhibitor | Nagashima, K; Shumway, SD; Sathyanarayanan, S; Chen, AH; Dolinski, B; Xu, Y; Keilhack, H; Nguyen, T; Wiznerowicz, M; Li, L; Lutterbach, BA; Chi, A; Paweletz, C; Allison, T; Yan, Y; Munshi, SK; Klippel, A; Kraus, M; Bobkova, EV; Deshmukh, S; Xu, Z; Mueller, U; Szewczak, AA; Pan, BS; Richon, V; Pollock, R; BlumeJensen, P; Northrup, A; Andersen, JN | 2011 | 133 |
| Pathway-based identification of biomarkers for targeted therapeutics: Personalized oncology with PI3K pathway inhibitors | Andersen, JN; Sathyanarayanan, S; Di Bacco, A; Chi, A; Zhang, T; Chen, AH; Dolinski, B; Kraus, M; Roberts, B; Arthur, W; Klinghoffer, RA; Gargano, D; Li, X; Feldman, I; Lynch, B; Rush, J; Hendrickson, RC; BlumeJensen, P; Paweletz, CP | 2010 | 70 |
|
